Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colonna

Showing results (181-190 of 292) with videos related to

Pageof 30
Sort By:
Bulletin Du Cancer|February 1, 1997
[Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department]D Moro, H Nagy-Mignotte, M Bolla, et al.
Cancer Epidemiology|January 15, 2013
National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct?Z Uhry, A Belot, M Colonna, et al.
Lancet (London, England)|September 3, 1988
Deletion of blood mitochondrial DNA in pancytopeniaA Rötig, M Colonna, S Blanche, et al.
Anesthesiology|January 1, 1994
Revised label regarding use of succinylcholine in children and adolescentsR C Morell, J M Berman, R I Royster, et al.
Human Immunology|December 1, 1990
Reassessment of HLA association with celiac disease in special reference to the DP associationM Colonna, W Mantovani, G R Corazza, et al.
Breast Cancer Research and Treatment|January 5, 2002
Survival of women with breast cancer in france: variation with age, stage and treatmentP Grosclaude, M Colonna, G Hedelin, et al.
Journal of Leukocyte Biology|June 25, 1999
Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamilyA H Banham, M Colonna, M Cella, et al.
British Journal of Haematology|September 21, 2000
Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell typeT Hoffmann, G De Libero, M Colonna, et al.
Journal Des Maladies Vasculaires|April 16, 2016
Low incidence of cancer after venous thromboembolism: An update from the French OPTIMEV CohortA-C Arnoult, G Pernod, C Genty, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
Pageof 30

Showing results (181-190 of 292) with videos related to

Sort By:
Pageof 30
Bulletin Du Cancer|February 1, 1997
[Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department]D Moro, H Nagy-Mignotte, M Bolla, et al.
Cancer Epidemiology|January 15, 2013
National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct?Z Uhry, A Belot, M Colonna, et al.
Lancet (London, England)|September 3, 1988
Deletion of blood mitochondrial DNA in pancytopeniaA Rötig, M Colonna, S Blanche, et al.
Anesthesiology|January 1, 1994
Revised label regarding use of succinylcholine in children and adolescentsR C Morell, J M Berman, R I Royster, et al.
Human Immunology|December 1, 1990
Reassessment of HLA association with celiac disease in special reference to the DP associationM Colonna, W Mantovani, G R Corazza, et al.
Breast Cancer Research and Treatment|January 5, 2002
Survival of women with breast cancer in france: variation with age, stage and treatmentP Grosclaude, M Colonna, G Hedelin, et al.
Journal of Leukocyte Biology|June 25, 1999
Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamilyA H Banham, M Colonna, M Cella, et al.
British Journal of Haematology|September 21, 2000
Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell typeT Hoffmann, G De Libero, M Colonna, et al.
Journal Des Maladies Vasculaires|April 16, 2016
Low incidence of cancer after venous thromboembolism: An update from the French OPTIMEV CohortA-C Arnoult, G Pernod, C Genty, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
Pageof 30